Table 3.
Effects of volatile anesthetics on oxidative stress and inflammation in humans.
| Subject of study | Anesthetics | Effects | References |
|---|---|---|---|
| Patients (elective lower abdominal surgery) |
Isoflurane, sevoflurane | Increased DNA damage | [43] |
|
| |||
| Patients (orthopedic surgery) |
Sevoflurane | Increased DNA damage | [44] |
|
| |||
| Patients (elective hysterectomy) |
Isoflurane | Increased inflammation response | [45] |
|
| |||
| Patients (elective cholecystectomy) |
Isoflurane | Increased inflammation response | [46] |
|
| |||
| Patients (elective thoracotomy lobectomy) |
Sevoflurane | Pulmonary dysfunction by increased inflammation response | [47] |
|
| |||
| Patients (otorhinological surgery) |
Isoflurane, sevoflurane | No alteration of DNA damage | [48] |
|
| |||
| Patients (otorhinological surgery) |
Isoflurane | No alteration of DNA damage | [49] |
|
| |||
| Patients (abdominal surgery) |
Sevoflurane | Antioxidant activity | [50] |
|
| |||
| Patients (otorhinological surgery) |
Isoflurane | No induction of oxidative stress | [51] |
| No induction of inflammation | |||
|
| |||
| Patients (otorhinological surgery) |
Sevoflurane | No alteration of redox state | [52] |
|
| |||
| Patients (open thoracic surgery) |
Sevoflurane | Anti-inflammatory effects | [53] |
|
| |||
| Patients (open thoracic surgery) |
Sevoflurane | Anti-inflammatory effects | [54] |
|
| |||
| Patients (otorhinological surgery) |
Isoflurane, sevoflurane | No alteration of cytokine profiles | [55] |
|
| |||
| Operating room personnel | Sevoflurane | No alteration of DNA damage | [56] |
|
| |||
| Operating room personnel | Isoflurane | Increased DNA damage | [57] |